Nicotinamide attenuates aquaporin 3 overexpression induced by retinoic acid through inhibition of EGFR/ERK in cultured human skin keratinocytes

International Journal of Molecular Medicine

Volumn 22, Issue 2, 2008, Pages 229-236

  Song, Xiuzu ^a,b   Xu, Aie ^a   Pan, Wei ^b   Wallin, Brittany ^b   Kivlin, Rebecca ^b   Lu, Shan ^b   Cao, Cong ^c   Bi, Zhigang ^d   Wan, Yinsheng ^b  

^a Third Hospital of Hangzhou   (China)

^b PROVIDENCE COLLEGE   (United States)

^c BROWN UNIVERSITY   (United States)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Aquaporin 3; EGFR; ERK; Nicotinamide; Retinoic acid

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; AQUAPORIN 3; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE; RETINOIC ACID;

ARTICLE; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENTIATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KERATINOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; WATER LOSS; WATER PERMEABILITY;

ANIMALS; AQUAPORIN 3; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KERATINOCYTES; KERATOLYTIC AGENTS; MAP KINASE SIGNALING SYSTEM; NIACINAMIDE; PERMEABILITY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; SKIN; TRETINOIN; VITAMIN B COMPLEX;

EID: 48749113488     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm_00000013     Document Type: Article

References (40)

1. Fisher GJ and Voorhees JJ: Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo. J Investig Dermatol Symp Proc 3: 61-68, 1998.
2. Lowe N, Gifford M, Tanghetti E, Poulin Y, Goldman M, Tse Y, Yamauchi P, Rosenzweig H and Kang S: Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study. J Cosmet Laser Ther 6: 79-85, 2004.
3. Effendy I, Weltfriend S, Patil S and Maibach HI: Differential irritant skin responses to topical retinoic acid and sodium lauryl sulphate: alone and in crossover design. Br J Dermatol 134: 424-430, 1996.
4. Tagami H, Tadaki T, Obata M and Koyama J: Functional assessment of the stratum corneum under the influence of oral aromatic retinoid (etretinate) in guinea-pigs and humans. Comparison with topical retinoic acid treatment. Br J Dermatol 127: 470-475, 1992.
5. Ale SI, Laugier JP and Maibach HI: Differential irritant skin responses to tandem application of topical retinoic acid and sodium lauryl sulphate: II. Effect of time between first and second exposure. Br J Dermatol 137: 226-233, 1997.
6. Hara M, Ma T and Verkman AS: Selectively reduced glycerol in skin of aquaporin-3-deficient mice may account for impaired skin hydration, elasticity, and barrier recovery. J Biol Chem 277: 46616-46621, 2002.
7. Sougrat R, Morand M, Gondran C, Barre P, Gobin R, Bonte F, Dumas M and Verbavatz JM: Functional expression of AQP3 in human skin epidermis and reconstructed epidermis. J Invest Dermatol 118: 678-685, 2002.
8. Agren J, Zelenin S, Hakansson M, Eklof AC, Aperia A, Nejsum LN, Nielsen S and Sedin G: Transepidermal water loss in developing rats: role of aquaporins in the immature skin. Pediatr Res 53: 558-565, 2003.
9. Olsson M, Broberg A, Jernas M, Carlsson L, Rudemo M, Suurkula M, Svensson PA and Benson M: Increased expression of aquaporin 3 in atopic eczema. Allergy 61: 1132-1137, 2006.
10. Bellemere G, Von Stetten O and Oddos T: Retinoic acid increases aquaporin 3 expression in normal human skin. J Invest Dermatol 128: 542-548, 2008.
11. Jacobson EL, Kim H, Kim M, Williams JD, Coyle DL, Coyle WR, Grove G, Rizer RL, Stratton MS and Jacobson MK: A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Exp Dermatol 16: 490-499, 2007.
12. Tashtoush BM, Kim H, Jacobson EL and Jacobson MK: Formulation compatibility of myristyl nicotinate with drugs used to treat dermatological conditions involving an impaired skin barrier. Drug Dev Ind Pharm 33: 1176-1182, 2007.
13. Greatens A, Hakozaki T, Koshoffer A, Epstein H, Schwemberger S, Babcock G, Bissett D, Takiwaki H, Arase S, Wickett RR and Boissy RE: Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible. Exp Dermatol 14: 498-508, 2005.
14. Gehring W: Nicotinic acid/niacinamide and the skin. J Cosmet Dermatol 3: 88-93, 2004.
15. Tanno O, Ota Y, Kitamura N, Katsube T and Inoue S: Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol 143: 524-531, 2000.
16. Jacobson MK, Kim H, Coyle WR, Kim M, Coyle DL, Rizer RL and Jacobson EL: Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage. Exp Dermatol 16: 927-935, 2007.
17. Rittie L, Varani J, Kang S, Voorhees JJ and Fisher GJ: Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J Invest Dermatol 126: 732-739, 2006.
18. Cao C, Wan S, Jiang Q, Amaral A, Lu S, Hu G, Hi Z, Kouttab N, Chu W and Wan Y: All-trans retinoic acid attenuates ultraviolet radiation-induced down-regulation of aquaporin-3 and water permeability in human keratinocytes. J Cell Physiol, on line, 2007.
19. Pasonen-Seppanen SM, Maytin EV, Torronen KJ, Hyttinen JM, Hascall VC, Maccallum DK, Kultti AH, Jokela TA, Tammi MI and Tammi RH: All-trans retinoic acid-induced hyaluronan production and hyperplasia are partly mediated by EGFR signaling in epidermal keratinocytes. J Invest Dermatol 128: 797-807, 2008.
20. Canon E, Cosgaya JM, Scsucova S and Aranda A: Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. Mol Biol Cell 15: 5583-5592, 2004.
21. Zhang QS, Maddock DA, Chen JP, Heo S, Chiu C, Lai D, Souza K, Mehta S and Wan YS: Cytokine-induced p38 activation feedback regulates the prolonged activation of AKT cell survival pathway initiated by reactive oxygen species in response to UV irradiation in human keratinocytes. Int J Oncol 19: 1057-1061, 2001.
22. Cao C, Sun Y, Healey S, Bi Z, Hu G, Wan S, Kouttab N, Chu W and Wan Y: EGFR-mediated expression of aquaporin-3 is involved in human skin fibroblast migration. Biochem J 400: 225-234, 2006.
23. Zelenina M, Bondar AA, Zelenin S and Aperia A: Nickel and extracellular acidification inhibit the water permeability of human aquaporin-3 in lung epithelial cells. J Biol Chem 278: 30037-30043, 2003.
24. Zelenina M, Tritto S, Bondar AA, Zelenin S and Aperia A: Copper inhibits the water and glycerol permeability of aquaporin-3. J Biol Chem 279: 51939-51943, 2004.
25. Zelenina M, Zelenin S, Bondar AA, Brismar H and Aperia A: Water permeability of aquaporin-4 is decreased by protein kinase C and dopamine. Am J Physiol Renal Physiol 283: F309-F318, 2002.
26. Tur E, Hohl D, Jetten A, Panizzon R and Frenk E: Modification of late epidermal differentiation in photoaged skin treated with topical retinoic acid cream. Dermatology 191: 124-128, 1995.
27. Kimura T and Doi K: Effects of all-trans-retinoic acid on the dorsal skin of hairless dogs. Toxicol Pathol 26: 595-601, 1998.
28. Weiss JS, Shavin JS, Nighland M and Grossman R: Tretinoin microsphere gel 0.1% for photodamaged facial skin: a placebo-controlled trial. Cutis 78: 426-432, 2006.
29. Phillips TJ: An update on the safety and efficacy of topical retinoids. Cutis 75: 14-22, 2005.
30. Chiu PC, Chan CC, Lin HM and Chiu HC: The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial. J Cosmet Dermatol 6: 243-249, 2007.
31. Kobayashi M and Shimizu S: Nicotinic acid and nicotinamide. Nippon Rinsho 57: 2211-2217, 1999.
32. Hara-Chikuma M and Verkman AS: Aquaporin-3 functions as a glycerol transporter in mammalian skin. Biol Cell 97: 479-486, 2005.
33. Hara-Chikuma M and Verkman AS: Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med 86: 221-231, 2008.
34. Levin MH and Verkman AS: Aquaporin-3-dependent cell migration and proliferation during corneal re-epithelialization. Invest Ophthalmol Vis Sci 47: 4365-4372, 2006.
35. Eberlein-Konig B, Schafer T, Huss-Marp J, Darsow U, Mohrenschlager M, Herbert O, Abeck D, Kramer U, Behrendt H and Ring J: Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol 80: 188-191, 2000.
36. Hon KL, Wong KY, Leung TF, Chow CM and Ng PC: Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol 9: 45-50, 2008.
37. Seidenari S and Giusti G: Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 75: 429-433, 1995.
38. Soma Y, Kashima M, Imaizumi A, Takahama H, Kawakami T and Mizoguchi M: Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol 44: 197-202, 2005.
39. Bissett D: Topical niacinamide and barrier enhancement. Cutis 70: 8-12, 2002.
40. Bissett DL, Oblong JE and Berge CA: Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg 31: 860-865, 2005.